RE-BVS – Piemonte Repository

Sfoglia per AUTORE
RUSCONI S
Collezione ASL Città di Torino

Items : 33

Question and answers on long-acting therapy with cabotegravir and rilpivirine in people with HIV. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2025 Mar 3;80(3):610-623. doi: 10.1093/jac/dkaf025.

2025
ASL Città di Torino

Lo Caputo S; Guaraldi G; Gianotti N; Di Biagio A; Cingolani A; Bonora S; Taramasso L; Madeddu G; Maggi P; Marchetti G; Nozza S; Rusconi S; Maggiolo F;

Serum and CSF biomarkers in asymptomatic patients during primary HIV infection: a randomized study. in Brain : a journal of neurology / Brain. 2024 Nov 4;147(11):3742-3750. doi: 10.1093/brain/awae271.

2024
ASL Città di Torino

Gulminetti R; Ripamonti D; Muscatello A; Antinori A; Gabrieli A; Rusconi S; Bruzzesi E; Trunfio M; Bernasconi D; Marchetti G; Cinque P; Cusato J; Calcagno A; Antonucci M; Nozza S;

Investigating coping and stigma in people living with HIV through narrative medicine in the Italian multicentre non-interventional study DIAMANTE. in Scientific reports / Sci Rep. 2023 Oct 17;13(1):17624. doi: 10.1038/s41598-023-44768-2.

2023
ASL Città di Torino

Antinori A; Vergori A; Ripamonti D; Valenti D; Esposito V; Carleo MA; Rusconi S; Cascio A; Manzillo E; Andreoni M; Orofino G; Cappuccio A; Reale L; Marini MG; Mancusi D; Termini R; Uglietti A; Portaro M;

Pillars of long-term antiretroviral therapy success. in Pharmacological research / Pharmacol Res. 2023 Oct;196:106898. doi: 10.1016/j.phrs.2023.106898. Epub 2023 Aug 28.

2023
ASL Città di Torino

Taramasso L; Andreoni M; Antinori A; Bandera A; Bonfanti P; Bonora S; Borderi M; Castagna A; Cattelan AM; Celesia BM; Cicalini S; Cingolani A; Cossarizza A; D'Arminio Monforte A; D'Ettorre G; Di Biagio A; Di Giambenedetto S; Di Perri G; Esposito V; Focà E; Gervasoni C; Gori A; Gianotti N; Guaraldi G; Gulminetti R; Lo Caputo S; Madeddu G; Maggi P; Marandola G; et alii...

Lipids and Transaminase in Antiretroviral-Treatment-Experienced People Living with HIV, Switching to a Doravirine-Based vs. a Rilpivirine-Based Regimen: Data from a Real-Life Setting. in Viruses / Viruses. 2023 Jul 23;15(7):1612. doi: 10.3390/v15071612.

2023
AOU Alessandria
ASL Città di Torino
AOU Novara

Bonfanti P; Di Biagio A; Cenderello G; Ferrara S; Falasca K; Bargiacchi O; Martini S; Sarchi E; Calza L; Rusconi S; Valsecchi L; Parisini A; Taramasso L; Carleo MA; Cascio A; Pellicanò GF; Madeddu G; Celesia BM; Vichi F; Bellagamba R; Orofino G; Menzaghi B; Masiello A; Molteni C; Squillace N; De Socio GV; Ricci ED; Martinelli CV; Maggi P; et alii...

Incident diabetes in course of antiretroviral therapy. in AIDS (London, England) / AIDS. 2023 Jul 1;37(8):1269-1276. doi: 10.1097/QAD.0000000000003548. Epub 2023 Mar 14.

2023
AOU Alessandria
ASL Città di Torino

Gulminetti R; Sarchi E; Cascio A; Pellicanò GF; Maggi P; Rusconi S; Celesia BM; Valsecchi L; Vichi F; Madeddu G; Martinelli CV; Socio GV; Molteni C; Orofino G; Ricci E; Menzaghi B; Squillace N; Taramasso L; Falasca K; Di Biagio A; Bonfanti P;

Reduced probability of improving viro-immunological state in subjects with vertical transmission of HIV reaching adult age: A multicenter retrospective cohort study. in Immunity, inflammation and disease / Immun Inflamm Dis. 2023 Feb;11(2):e778. doi: 10.1002/iid3.778.

2023
ASL Città di Torino

Pennati F; Calza S; Di Biagio A; Mussini C; Rusconi S; Bonora S; Borghetti A; Quiros-Roldan E; Sarteschi G; Menozzi M; Ferrara M; Celotti A; Ciccullo A; Giacomet V; Izzo I; Dotta L; Badolato R; Castelli F; Focà E;

Durability of Dolutegravir-Based Regimens: A 5-Year Prospective Observational Study. in AIDS patient care and STDs / AIDS Patient Care STDS. 2021 Sep;35(9):342-353. doi: 10.1089/apc.2021.0089.

2021
AOU Alessandria
ASL Città di Torino

Dentone C; Bandera A; Cenderello G; Guadagnino G; Angioni G; Vichi F; Maggi P; Cascio A; Martinelli CV; Valsecchi L; Rusconi S; Calza L; Celesia BM; Sarchi E; Pellicanò GF; De Socio GV; Gulminetti R; Molteni C; Menzaghi B; Squillace N; Ricci ED; Orofino G; Taramasso L; De Vito A; Falasca K; Bonfanti P; Di Biagio A; Madeddu G;

Predictors of incomplete viral response and virologic failure in patients with acute and early HIV infection. Results of Italian Network of ACuTe HIV InfectiON (INACTION) cohort. in HIV medicine / HIV Med. 2020 Sep;21(8):523-535. doi: 10.1111/hiv.12885. Epub 2020 Jun 24.

2020
ASL Città di Torino

Taramasso L; Fabbiani M; Nozza S; De Benedetto I; Bruzzesi E; Mastrangelo A; Pinnetti C; Calcagno A; Ferrara M; Bozzi G; Focà E; Quiros-Roldan E; Ripamonti D; Campus M; Celesia BM; Torti C; Cosco L; Di Biagio A; Rusconi S; Marchetti G; Mussini C; Gulminetti R; Cingolani A; d'Ettorre G; Madeddu G; Franco A; Orofino G; Squillace N; Muscatello A; et alii...

Factors associated with hospital admission for COVID-19 in HIV patients. in AIDS (London, England) / AIDS. 2020 Nov 1;34(13):1983-1985. doi: 10.1097/QAD.0000000000002663.

2020
ASL Città di Torino
AOU Novara

Falasca K; Maggi P; Saracino A; Ferrara S; Cenderello G; Valsecchi L; Molteni C; Bargiacchi O; Orofino G; Rusconi S; Menzaghi B; Squillace N; Calza L; Ricci E; Di Biagio A; Taramasso L; Bonfanti P;

Effectiveness of Switching to Darunavir/Cobicistat in Virologically Suppressed HIV-Positive Patients Receiving Ritonavir-Boosted Protease Inhibitor-Based Regimen: The "STORE" Study. in Journal of acquired immune deficiency syndromes (1999) / J Acquir Immune Defic Syndr. 2020 Jul 1;84(3):290-294. doi: 10.1097/QAI.0000000000002331.

2020
ASL Città di Torino

Gori A; Antinori A; Vergori A; Cossu MV; Menzaghi B; Sterrantino G; Rusconi S; Cattelan AM; Castelli F; Gianotti N; Orofino G; Ripamonti D; Savinelli S; Manzillo E; Santantonio TA; Celesia BM; Cauda R; Maserati R; d'Arminio Monforte A; Stingone C; Bonora S; Uglietti A; Termini R; Rucci F; Mancusi D;

Sitagliptin Treatment at the Time of Hospitalization Was Associated With Reduced Mortality in Patients With Type 2 Diabetes and COVID-19: A Multicenter, Case-Control, Retrospective, Observational Study. in Diabetes care / Diabetes Care. 2020 Dec;43(12):2999-3006. doi: 10.2337/dc20-1521. Epub 2020 Sep 29.

2020
ASL Città di Torino

Solerte SB; D'Addio F; Trevisan R; Lovati E; Rossi A; Pastore I; Dell'Acqua M; Ippolito E; Scaranna C; Bellante R; Galliani S; Dodesini AR; Lepore G; Geni F; Fiorina RM; Catena E; Corsico A; Colombo R; Mirani M; De Riva C; Oleandri SE; Abdi R; Bonventre JV; Rusconi S; Folli F; Di Sabatino A; Zuccotti G; Galli M; Fiorina P; et alii...

Enhanced Immunological Recovery With Early Start of Antiretroviral Therapy During Acute or Early HIV Infection-Results of Italian Network of ACuTe HIV InfectiON (INACTION) Retrospective Study. in Pathogens & immunity / Pathog Immun. 2020 Feb 24;5(1):8-33. doi: 10.20411/pai.v5i1.341. eCollection 2020.

2020
ASL Città di Torino

Muscatello A; Nozza S; Fabbiani M; De Benedetto I; Ripa M; Dell'acqua R; Antinori A; Pinnetti C; Calcagno A; Ferrara M; Focà E; Quiros-Roldan E; Ripamonti D; Campus M; Maurizio Celesia B; Torti C; Cosco L; Di Biagio A; Rusconi S; Marchetti G; Mussini C; Gulminetti R; Cingolani A; D'ettorre G; Madeddu G; Franco A; Orofino G; Squillace N; Gori A; et alii...

Impact of genotypic susceptibility score on cART outcomes during primary HIV infection. in Journal of medical virology / J Med Virol. 2019 Oct;91(10):1891-1895. doi: 10.1002/jmv.25517. Epub 2019 Jun 27.

2019
ASL Città di Torino

Giacomelli A; Fabbiani M; De Benedetto I; Nozza S; Focà E; Celesia BM; Marchetti G; Mussini C; Antinori A; d'Ettorre G; Madeddu G; Bandera A; Muscatello A; Rusconi S;

The Effect of Switching to Maraviroc + Darunavir/Ritonavir Dual Therapy in Virologically Suppressed Patients on the Progression of Liver Fibrosis: Findings From a Randomized Study. in Journal of acquired immune deficiency syndromes (1999) / J Acquir Immune Defic Syndr. 2019 May 1;81(1):e17-e21. doi: 10.1097/QAI.0000000000001986.

2019
ASL Città di Torino

Rossetti B; Gagliardini R; Sterrantino G; Colangeli V; Latini A; Colafigli M; Vignale F; Rusconi S; Di Biagio A; Orofino G; Mezzaroma I; Vullo V; Francisci D; Mastroianni C; Trezzi M; Canovari B; Lamonica S; Ciccullo A; Borghetti A; D?Arminio Monforte A; Di Giambenedetto S; De Luca A;

Switch to dolutegravir and unboosted atazanavir in HIV-1 infected patients with undetectable viral load and long exposure to antiretroviral therapy. in AIDS (London, England) / AIDS. 2019 Jun 1;33(7):1256-1260. doi: 10.1097/QAD.0000000000002188.

2019
ASL Città di Torino

Castagna A; Rusconi S; Gulminetti R; Bonora S; Mazzola G; Quiros-Roldan ME; De Socio GV; Ladisa N; Carosella S; Cattelan A; Di Giambenedetto S; Mena M; Poli A; Galli L; Riva A;

Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohort. in Journal of the International AIDS Society / J Int AIDS Soc. 2019 Jan;22(1):e25227. doi: 10.1002/jia2.25227.

2019
ASL Città di Torino

Mondi A; Cozzi-Lepri A; Tavelli A; Rusconi S; Vichi F; Ceccherini-Silberstein F; Calcagno A; De Luca A; Maggiolo F; Marchetti G; Antinori A; d'Arminio Monforte A;

Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2018 Jul 1;73(7):1955-1964. doi: 10.1093/jac/dky123.

2018
ASL Città di Torino

Fabbiani M; Gagliardini R; Ciccarelli N; Quiros Roldan E; Latini A; d'Ettorre G; Antinori A; Castagna A; Orofino G; Francisci D; Chinello P; Madeddu G; Grima P; Rusconi S; Del Pin B; Lombardi F; D'Avino A; Focà E; Colafigli M; Cauda R; Di Giambenedetto S; De Luca A;

Dolutegravir Plus Rilpivirine as a Switch Option in cART-Experienced Patients: 96-Week Data. in The Annals of pharmacotherapy / Ann Pharmacother. 2018 Aug;52(8):740-746. doi: 10.1177/1060028018761600. Epub 2018 Feb 26.

2018
ASL Città di Torino

Capetti AF; Cossu MV; Sterrantino G; Barbarini G; Di Giambenedetto S; De Socio GV; Orofino G; Di Biagio A; Celesia BM; Rusconi S; Argenteri B; Rizzardini G;

A dual regimen of ritonavir/darunavir plus dolutegravir for rescue or simplification of rescue therapy: 48 weeks' observational data. in BMC infectious diseases / BMC Infect Dis. 2017 Sep 30;17(1):658. doi: 10.1186/s12879-017-2755-4.

2017
ASL Città di Torino

Capetti AF; Cossu MV; Orofino G; Sterrantino G; Cenderello G; De Socio GV; Cattelan AM; Soria A; Rusconi S; Riccardi N; Baldin GM; Niero FP; Barbarini G; Rizzardini G;

Discontinuation of treatment and adverse events in an Italian cohort of patients on dolutegravir. in AIDS (London, England) / AIDS. 2017 Jan 28;31(3):455-457. doi: 10.1097/QAD.0000000000001351.

2017
ASL Città di Torino

Bonfanti P; Madeddu G; Gulminetti R; Squillace N; Orofino G; Vitiello P; Rusconi S; Celesia BM; Maggi P; Ricci E;

Efficacy, safety and pharmacokinetics of atazanavir (200mg twice daily) plus raltegravir (400mg twice daily) dual regimen in the clinical setting. in Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology / J Clin Virol. 2017 Feb;87:30-36. doi: 10.1016/j.jcv.2016.11.015. Epub 2016 Dec 1.

2017
ASL Città di Torino

Marinaro L; Calcagno A; Ripamonti D; Cenderello G; Pirriatore V; Trentini L; Salassa B; Bramato C; Orofino G; D'Avolio A; Rizzi M; Di Perri G; Rusconi S; Bonora S;

Weight Gain: A Possible Side Effect of All Antiretrovirals. in Open forum infectious diseases / Open Forum Infect Dis. 2017 Nov 3;4(4):ofx239. doi: 10.1093/ofid/ofx239. eCollection 2017 Fall.

2017
ASL Città di Torino

Taramasso L; Ricci E; Menzaghi B; Orofino G; Passerini S; Madeddu G; Martinelli CV; De Socio GV; Squillace N; Rusconi S; Bonfanti P; Di Biagio A;

Treatment simplification to atazanavir/ritonavir?+?lamivudine versus maintenance of atazanavir/ritonavir?+?two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M). in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2017 Apr 1;72(4):1163-1171. doi: 10.1093/jac/dkw557.

2017
ASL Città di Torino

Di Giambenedetto S; Fabbiani M; Quiros Roldan E; Latini A; D'Ettorre G; Antinori A; Castagna A; Orofino G; Francisci D; Chinello P; Madeddu G; Grima P; Rusconi S; Di Pietro M; Mondi A; Ciccarelli N; Borghetti A; Focà E; Colafigli M; De Luca A; Cauda R;

Proportion and factors associated with recent HIV infection in a cohort of patients seen for care in Italy over 1996-2014: Data from the ICONA Foundation Study cohort. in PloS one / PLoS One. 2017 Dec 5;12(12):e0189045. doi: 10.1371/journal.pone.0189045. eCollection 2017.

2017
ASL Città di Torino

Nozza S; Cozzi-Lepri A; Bai F; Rusconi S; Gori A; Cinque P; Ammassari A; Caramello P; Tambussi G; D'Arminio Monforte A; Marchetti G;

Safety and tolerability of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil fumarate in a real life setting: Data from surveillance cohort long-term toxicity antiretrovirals/antivirals (SCOLTA) project. in PloS one / PLoS One. 2017 Jun 20;12(6):e0179254. doi: 10.1371/journal.pone.0179254. eCollection 2017.

2017
ASL Città di Torino

Squillace N; Ricci E; Quirino T; Gori A; Bandera A; Carenzi L; De Socio GV; Orofino G; Martinelli C; Madeddu G; Rusconi S; Maggi P; Celesia BM; Cordier L; Vichi F; Calza L; Falasca K; Di Biagio A; Pellicanò GF; Bonfanti P;

Switch to maraviroc with darunavir/r, both QD, in patients with suppressed HIV-1 was well tolerated but virologically inferior to standard antiretroviral therapy: 48-week results of a randomized trial. in PloS one / PLoS One. 2017 Nov 21;12(11):e0187393. doi: 10.1371/journal.pone.0187393. eCollection 2017.

2017
ASL Città di Torino

Rossetti B; Gagliardini R; Meini G; Sterrantino G; Colangeli V; Re MC; Latini A; Colafigli M; Vignale F; Rusconi S; Micheli V; Di Biagio A; Orofino G; Ghisetti V; Fantauzzi A; Vullo V; Grima P; Francisci D; Mastroianni C; Antinori A; Trezzi M; Lisi L; Navarra P; Canovari B; D'Arminio Monforte A; Lamonica S; D'Avino A; Zazzi M; Di Giambenedetto S; et alii...

Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: data from the ICONA cohort. in Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases / Clin Microbiol Infect. 2016 Mar;22(3):288.e1-8. doi: 10.1016/j.cmi.2015.10.026. Epub 2015 Nov 10.

2016
ASL Città di Torino

Mussini C; Abrescia N; Caramello P; Rusconi S; Bonfanti P; Castelli F; Girardi E; Lo Caputo S; Lorenzini P; Saracino A; Monno L; d'Arminio Monforte A;

An update on integrase inhibitors: new opportunities for a personalized therapy? The NEXTaim Project. in The new microbiologica / New Microbiol. 2015 Oct;38(4):443-90.

2015
ASL Città di Torino

Andreoni M; Marcotullio S; Puro V; De Carli G; Tambussi G; Nozza S; Gori A; Rusconi S; Santoro MM; Clementi M; Perno CF; d'Arminio Monforte A; Maggiolo F; Castagna A; De Luca A; Galli M; Giacomelli A; Borderi M; Guaraldi G; Calcagno A; Di Perri G; Bonora S; Mussini C; Di Biagio A; Puoti M; Bruno R; Zuccaro V; Antinori A; Cinque P; et alii...

Treatment outcome in HIV+ patients receiving 3- or 4-drug regimens during PHI. in Journal of the International AIDS Society / J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19778. doi: 10.7448/IAS.17.4.19778. eCollection 2014.

2014
ASL Città di Torino

Bottani GM; Oreni ML; Orofino G; Tau P; Di Nardo Stuppino S; Colella E; Carosella S; Guastavigna M; Ghisetti V; Micheli V; Galli M; Rusconi S;

Safety and therapeutic efficacy of the switch to maraviroc+darunavir/ritonavir in HIV/HCV coinfected patients: initial results from GUSTA study. in Journal of the International AIDS Society / J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19818. doi: 10.7448/IAS.17.4.19818. eCollection 2014.

2014
ASL Città di Torino

Gagliardini R; Rossetti B; Bianco C; Rusconi S; Colafigli M; Prinapori R; Francisci D; Fantauzzi A; Orofino G; Vignale F; Di Giambenedetto S; De Luca A;

Simplification to atazanavir/ritonavir+lamivudine in virologically suppressed HIV-infected patients: 24-weeks interim analysis from ATLAS-M trial. in Journal of the International AIDS Society / J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19808. doi: 10.7448/IAS.17.4.19808. eCollection 2014.

2014
ASL Città di Torino

Fabbiani M; Di Giambenedetto S; Quiros-Roldan E; Latini A; Vullo V; Antinori A; Castagna A; Orofino G; Francisci D; Grilli E; Madeddu G; Grima P; Rusconi S; Del Pin B; Mondi A; Borghetti A; Focà E; Colafigli M; De Luca A; Cauda R;

Efficacy, tolerability and virological consequences of long-term use of unboosted atazanavir plus 2 NRTIs in HIV-infected patients. in Current HIV research / Curr HIV Res. 2014;12(5):339-46. doi: 10.2174/1570162x12666140807151616.

2014
ASL Città di Torino

Bonora S; Calcagno A; Vigano O; Bigliano P; Marinaro L; Colella E; Orofino G; Trentini L; Tettoni MC; D'Avolio A; Mercadante S; Galli M; Di Perri G; Rusconi S;